Fusion Pharmaceuticals Inc. Gains 21.76%
Tue, Feb 14, 2023 at 07:16 PM
Fusion Pharmaceuticals Inc. (FUSN:NASDAQ) jumped higher at $4.42, representing a gain of 21.8%. On Tue, Feb 14, 2023, FUSN:NASDAQ touched a New 2-Week High of $4.42. The stock appeared on our News Catalysts scanner on Tue, Feb 14, 2023 at 10:11 AM in the 'BIOTECH' category. From Tue, Jan 31, 2023, the stock recorded 80.00% Up Days and 36.36% Green Days
About Fusion Pharmaceuticals Inc. (FUSN:NASDAQ)
Fusion Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing alpha therapeutics for curing cancer.
Top 10 Gainers:
- Amesite Inc. (AMST:NASDAQ), 81.62%
- Boxlight Corporation (BOXL:NASDAQ), 39.47%
- United Insurance Holdings Corp. (UIHC:NASDAQ), 37.27%
- Blue Water Vaccines Inc. (BWV:NASDAQ), 33.33%
- OneConnect Financial Technology Co., Ltd. (OCFT:NYSE), 29.7%
- Secoo Holding Limited (SECO:NASDAQ), 24.82%
- SkyWater Technology Inc. (SKYT:NASDAQ), 22.31%
- Fusion Pharmaceuticals Inc. (FUSN:NASDAQ), 21.76%
- Palantir Technologies Inc. Class A (PLTR:NYSE), 21.16%
- Ouster Inc. (OUST:NYSE), 20.44%